The Expressions of Cancer Stem Cell Markers and Nonclassical HLA antigens in Breast Tumors

Objective: There is a strong relationship between the cancer stem cells (CSCs) and poor prognosis, metastasis and recurrence. In addition to this CSCs are resistant to chemotherapy and radiotherapy. Therefore, current treatment approaches may be ineffective to elimination of CSCs. The tumor cells ha...

Full description

Bibliographic Details
Main Authors: Rabia Bilge Özgül Özdemir, Alper Tunga Özdemir, Fatih Oltulu, Kamile Kurt, Gürkan Yiğittürk, Cengiz Kırmaz
Format: Article
Language:English
Published: Galenos Yayinevi 2017-09-01
Series:İstanbul Medical Journal
Subjects:
Online Access: http://imj.galenos.com.tr/archives/archive-detail/article-preview/the-expressions-of-cancer-stem-cell-markers-and-no/20486
_version_ 1797916388606607360
author Rabia Bilge Özgül Özdemir
Alper Tunga Özdemir
Fatih Oltulu
Kamile Kurt
Gürkan Yiğittürk
Cengiz Kırmaz
author_facet Rabia Bilge Özgül Özdemir
Alper Tunga Özdemir
Fatih Oltulu
Kamile Kurt
Gürkan Yiğittürk
Cengiz Kırmaz
author_sort Rabia Bilge Özgül Özdemir
collection DOAJ
description Objective: There is a strong relationship between the cancer stem cells (CSCs) and poor prognosis, metastasis and recurrence. In addition to this CSCs are resistant to chemotherapy and radiotherapy. Therefore, current treatment approaches may be ineffective to elimination of CSCs. The tumor cells have various adaptations for escaping from immune cells. The human leukocyte antigen (HLA) -G, which expressions restricted with fetal tissues and HLA-E are kind of tumor immune evasive adaptations. In this study, we aimed to investigate the relationship between the CSCs and immune evasive adaptations of breast tumors.Methods: We immunohistochemically evaluated that the expressions of cluster of differentiation (CD) 44, CD133, Homeobox protein Nanog, octamerbinding transcription factor (Oct) 3/4, HLA-G and HLA-E in the advanced stage breast cancer tissues (n=10) and the non-malignant breast biopsies (n=10).Results: We detected that the significantly increased expressions of especially Nanog (p<0.001) and also CD44 (p<0.001), CD133 (p<0.001) and Oct3/4 (p<0.001) in the advanced stage breast tumor group compared with non-malignant breast biopsies group, but the HLA-G (p<0.001) and HLA-E (p<0.001) decreased.Conclusion: These findings suggested that, malignant breast tumors may have CSC-like cells, and these cells may play role for occurring malignant behavior. To proliferation and tumor formation, the immune evasion is essential for both of malignant and benign tumors. Higher expressions of HLA-G and HLA-E may be an indication that the nonmalign tumors more immune evasive than the malign tumors. However, further prospective studies are needed to confirm our findings.
first_indexed 2024-04-10T12:56:24Z
format Article
id doaj.art-cfb6734989e1415a84ac567a1d98994d
institution Directory Open Access Journal
issn 2619-9793
2148-094X
language English
last_indexed 2024-04-10T12:56:24Z
publishDate 2017-09-01
publisher Galenos Yayinevi
record_format Article
series İstanbul Medical Journal
spelling doaj.art-cfb6734989e1415a84ac567a1d98994d2023-02-15T16:13:29ZengGalenos Yayineviİstanbul Medical Journal2619-97932148-094X2017-09-0118312813410.5152/imj.2017.6349713049054The Expressions of Cancer Stem Cell Markers and Nonclassical HLA antigens in Breast TumorsRabia Bilge Özgül Özdemir0Alper Tunga Özdemir1Fatih Oltulu2Kamile Kurt3Gürkan Yiğittürk4Cengiz Kırmaz5 Manisa State Hospital, Immunology And Allergy Clinic, Manisa, Turkey Department Of Stem Cell, Ege University Health Sciences Institute, İzmir, Turkey Department of Histology And Embryology, Ege University School of Medicine, İzmir, Turkey Merkezefendi State Hospital, Pathology Laboratory, Manisa, Turkey Department of Histology And Embryology, Ege University School of Medicine, İzmir, Turkey Department of Immunology And Allergy, Manisa Celal Bayar University School of Medicine, Manisa, Turkey Objective: There is a strong relationship between the cancer stem cells (CSCs) and poor prognosis, metastasis and recurrence. In addition to this CSCs are resistant to chemotherapy and radiotherapy. Therefore, current treatment approaches may be ineffective to elimination of CSCs. The tumor cells have various adaptations for escaping from immune cells. The human leukocyte antigen (HLA) -G, which expressions restricted with fetal tissues and HLA-E are kind of tumor immune evasive adaptations. In this study, we aimed to investigate the relationship between the CSCs and immune evasive adaptations of breast tumors.Methods: We immunohistochemically evaluated that the expressions of cluster of differentiation (CD) 44, CD133, Homeobox protein Nanog, octamerbinding transcription factor (Oct) 3/4, HLA-G and HLA-E in the advanced stage breast cancer tissues (n=10) and the non-malignant breast biopsies (n=10).Results: We detected that the significantly increased expressions of especially Nanog (p<0.001) and also CD44 (p<0.001), CD133 (p<0.001) and Oct3/4 (p<0.001) in the advanced stage breast tumor group compared with non-malignant breast biopsies group, but the HLA-G (p<0.001) and HLA-E (p<0.001) decreased.Conclusion: These findings suggested that, malignant breast tumors may have CSC-like cells, and these cells may play role for occurring malignant behavior. To proliferation and tumor formation, the immune evasion is essential for both of malignant and benign tumors. Higher expressions of HLA-G and HLA-E may be an indication that the nonmalign tumors more immune evasive than the malign tumors. However, further prospective studies are needed to confirm our findings. http://imj.galenos.com.tr/archives/archive-detail/article-preview/the-expressions-of-cancer-stem-cell-markers-and-no/20486 Breast tumorcancer stem cellhuman leukocyte antigen Ghuman leukocyte antigen Etumor immune evasion
spellingShingle Rabia Bilge Özgül Özdemir
Alper Tunga Özdemir
Fatih Oltulu
Kamile Kurt
Gürkan Yiğittürk
Cengiz Kırmaz
The Expressions of Cancer Stem Cell Markers and Nonclassical HLA antigens in Breast Tumors
İstanbul Medical Journal
Breast tumor
cancer stem cell
human leukocyte antigen G
human leukocyte antigen E
tumor immune evasion
title The Expressions of Cancer Stem Cell Markers and Nonclassical HLA antigens in Breast Tumors
title_full The Expressions of Cancer Stem Cell Markers and Nonclassical HLA antigens in Breast Tumors
title_fullStr The Expressions of Cancer Stem Cell Markers and Nonclassical HLA antigens in Breast Tumors
title_full_unstemmed The Expressions of Cancer Stem Cell Markers and Nonclassical HLA antigens in Breast Tumors
title_short The Expressions of Cancer Stem Cell Markers and Nonclassical HLA antigens in Breast Tumors
title_sort expressions of cancer stem cell markers and nonclassical hla antigens in breast tumors
topic Breast tumor
cancer stem cell
human leukocyte antigen G
human leukocyte antigen E
tumor immune evasion
url http://imj.galenos.com.tr/archives/archive-detail/article-preview/the-expressions-of-cancer-stem-cell-markers-and-no/20486
work_keys_str_mv AT rabiabilgeozgulozdemir theexpressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT alpertungaozdemir theexpressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT fatiholtulu theexpressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT kamilekurt theexpressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT gurkanyigitturk theexpressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT cengizkırmaz theexpressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT rabiabilgeozgulozdemir expressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT alpertungaozdemir expressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT fatiholtulu expressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT kamilekurt expressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT gurkanyigitturk expressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors
AT cengizkırmaz expressionsofcancerstemcellmarkersandnonclassicalhlaantigensinbreasttumors